How can we make enough vaccine for 2 billion people?

Credit: Unsplash

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum.

Author: Harry Kretchmer, Senior Writer, Formative Content


  • The World Health Organization and other groups want to make 2 billion doses of vaccine available for the globe’s poorest by late 2021.
  • Wealthier nations have already signed deals to secure multiple vaccinations for their populations.
  • Making billions of doses will take a global effort, requiring innovation, fast-track approvals and complex supply chains.

With the pandemic, the world’s focus has shifted to the creation of an effective vaccine. But once that vaccine is in place, the job of eradicating COVID is far from over. The next challenge will be getting that vaccine to the people who need it most, a project that requires the rapid creation of a vast global supply chain.

One of these plans, COVAX, is a scheme created to provide fast, equitable access to a COVID-19 vaccine around the world. COVAX is trying to raise sufficient funds to make 2 billion doses of effective vaccine available by late 2021.

But that goal could be missed if nations attempt to secure the majority of doses for themselves, which World Health Organization (WHO) Director-General, Tedros Adhanom Ghebreyesus, has called “vaccine nationalism.”

Coronavirus vaccine candidates
There are a number of different COVID-19 vaccines in development. Image: Nature

It starts in the lab

The first challenge is to make the vaccine, and it starts small. Around the world, COVID-19 is being grown in cells – kidney cells are commonly used – by teams developing coronavirus vaccines. These are cultured in vats called bioreactors.

Different types of vaccines need different amounts of virus to be produced. For instance, London’s Imperial College, which is working on an RNA-based genetic code vaccine, needs just 1 litre of virus for 200 million people. Conventional vaccines require thousands of litres.

While tiny amounts are needed for vaccine testing (a thousandth of a thousandth of a gram in the case of RNA), for at-risk global populations to be inoculated, vast material will be needed for many of the more than 100 “candidate” vaccine programmes to scale. https://www.youtube.com/embed/5opR6x6NMpQ?enablejsapi=1&wmode=transparent

Building alliances

“In the early stages of the programme, my team built a consortium with smaller manufacturers in the UK and the Netherlands to go from a three litre scale up to 200 litres,” Sandy Douglas from Oxford’s Jenner Institute tells the BBC. But the team realized they had to get even bigger.

For the Oxford vaccine – among the furthest advanced potential treatments – partnering with pharmaceutical giant AstraZeneca enabled capacity to be increased significantly, adding hundreds of staff to work on the vaccine. Four bioreactors, each with a 2,000-litre capacity, will allow the production of a billion doses of vaccine in two months, the Economist reports. coronavirus, health, COVID19, pandemic

What is the World Economic Forum doing to manage emerging risks from COVID-19?

The first global pandemic in more than 100 years, COVID-19 has spread throughout the world at an unprecedented speed. At the time of writing, 4.5 million cases have been confirmed and more than 300,000 people have died due to the virus.

As countries seek to recover, some of the more long-term economic, business, environmental, societal and technological challenges and opportunities are just beginning to become visible.

To help all stakeholders – communities, governments, businesses and individuals understand the emerging risks and follow-on effects generated by the impact of the coronavirus pandemic, the World Economic Forum, in collaboration with Marsh and McLennan and Zurich Insurance Group, has launched its COVID-19 Risks Outlook: A Preliminary Mapping and its Implications – a companion for decision-makers, building on the Forum’s annual Global Risks Report.

The report reveals that the economic impact of COVID-19 is dominating companies’ risks perceptions.

Companies are invited to join the Forum’s work to help manage the identified emerging risks of COVID-19 across industries to shape a better future. Read the full COVID-19 Risks Outlook: A Preliminary Mapping and its Implications report here, and our impact story with further information.

However, even AstraZeneca isn’t doing all the work alone. Its partners include the Serum Institute of India, which is preparing to manufacture 1 billion doses of the Oxford vaccine. Other potential vaccines in China and the US are also progressing quickly thanks to complex partnerships. https://platform.twitter.com/embed/index.html?dnt=false&embedId=twitter-widget-0&frame=false&hideCard=false&hideThread=false&id=1296031492703948802&lang=en&origin=https%3A%2F%2Fwww.weforum.org%2Fagenda%2F2020%2F08%2Fcovid-vaccine-manufacture-distribute-2-billion-doses%2F&theme=light&widgetsVersion=223fc1c4%3A1596143124634&width=550px

Working together and innovating

There are currently around 30 candidate vaccines at the more advanced “clinical evaluation” stage and almost 140 more in pre-clinical evaluation, according to the WHO.

Some vaccines could require multiple doses, meaning that potentially 4 billion doses could be needed for the most vulnerable.

Such volume can be more easily reached if companies work together. “No pharma company could make 5 billion doses in the next year or so,” Stéphane Bancel, CEO of biotech company Moderna tells the World Economic Forum’s COVID Action Platform. “But if several of us get to the finish line, then we should be able to put a big dent in the spread of the virus.”

How the vaccine is made can also facilitate fast manufacture at scale. The Oxford trial is employing “single use technologies” – essentially making vaccines in disposable plastic bags – Sandy Douglas tells the BBC. This has made production much easier and less vulnerable to shortages of glassware and other products.

“We need hundreds or thousands of input materials and a shortage of any one of them could derail the whole thing,” says Douglas. To make the supply chain as robust as possible, his team has made sure alternative components can be substituted in if needed.

The COVAX project aims to make 2 billion doses available to the world’s poorest people.
The COVAX project aims to make 2 billion doses available to the world’s poorest people. Image: Gavi

Delivering where it’s needed most

But making a vaccine in record time will be of limited use if the people who need it most are denied access. This is the concern and motivation behind COVAX, the project led by the WHO, Gavi, the Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI).

The programme is designed to pool funds from wealthy nations and nonprofits to develop and distribute a COVID-19 vaccine equitably. It is aiming to deliver 2 billion approved doses by late 2021. The idea is that high-income countries buy vaccines through COVAX and poorer, “funded” countries receive financial assistance.

However, last month the WHO warned that its $2 billion funding target was some way off being met, with around $600 million having been raised and not enough nations signing up.

At the same time, some nations have spent billions of dollars on deals with multiple manufacturers, securing hundreds of millions of doses for their own use.

“We need to prevent vaccine nationalism,” says Tedros Adhanom Ghebreyesus. “As we accelerate the science, solidarity is needed to provide a joint solution to the pandemic.”

Making 2 billion vaccine doses will be an extraordinary achievement; putting them to the best use could be another.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

More funds needed to counter ‘persistent and multi-faceted humanitarian problems’ in Ethiopia

Commission publishes guidance on coronavirus-related humanitarian aid to Syria despite sanctions

Teamgum @ TheNextWeb 2014

A letter from Italy: Our insecurity in COVID-19 times

Companies that put employees first perform better

Vile act of torture prohibited ‘under all circumstances’, UN chief affirms on International Day to support victims

The power of partnership: joining forces to fight financial crime

Speak up for health care workers’ safety

Intervene, don’t overthink – the new mantra of systems design

8000 young people in the EP in Strasbourg: “a breath of fresh air for EU democracy”

This is what happened to CO2 emissions in the EU last year

From Israel’s ‘start-up nation’, 4 lessons in innovation

3.7 million lives could be saved by 2025 if health services ramp up nutrition actions: WHO

You can live up to 10 years longer by doing these 5 things

Statement by OECD Secretary-General Angel Gurría on the outcome of COP 25

Italian Prime Minister Giuseppe Conte: “Europe must listen to the people”

Integration of migrants: Commission launches a public consultation and call for an expert group on the views of migrants

European Youth Forum welcomes strong stance on human rights in State of the Union

Why rich countries are seeing more poverty

Quality of air in Bucharest-Romania: is it fog or is it smog?

Commission reaches agreement with collaborative economy platforms to publish key data on tourism accommodation

This is how we can feed the planet while saving the ocean

Genocide threat for Myanmar’s Rohingya greater than ever, investigators warn Human Rights Council

Mental health and suicide prevention

World Migratory Bird Day highlights deadly risks of plastic pollution

UN chief expresses solidarity with Indonesian authorities after flash floods kill dozens in Papua

‘Path to peace’ on Korean Peninsula only possible through diplomacy and full denuclearization: US tells Security Council

9 climate tipping points pushing Earth to the point of no return

EU Ombudsman investigates the European Commission

Humanitarian aid: €7 million for disaster preparedness in Southern Africa and Indian Ocean region

MEPs approve €585 million to support refugees from Syria

How can we make entrepreneurship serve the greater good?

Can the world take the risk of a new financial armageddon so that IMF doesn’t lose face towards Tsipras?

We need to build a quantum security coalition. Here’s why

A Sting Exclusive: “The challenge of Society’s digital transformation”, Spanish Minister of Spain for Industry, Energy and Tourism José Manuel Soria live from European Business Summit 2015

China’s lead in the global solar race – at a glance

How COVID-19 can be the Great Reset toward global sustainability

UN food agency begins ‘last resort’ partial withdrawal of aid to opposition-held Yemeni capital

The World Bank’s 2020 country classifications explained

Venezuela: Competing US, Russia resolutions fail to pass in Security Council

On Kristallnacht anniversary, UN chief urges renewed fight against ‘crime’ of anti-Semitism

The EU has to prove it can remain one piece

Politics needs to “Youth UP” in order the ensure the future of our democracies

5 reasons to protect mangrove forests for the future

States with power and influence to end suffering of Yemenis must take action ‘immediately’ – UN rights chief

COVID-19: Both WHO and Europe must learn from the current pandemic, say MEPs

Italy’s revised budget remains roughly unchanged waiting for Europe’s fury

Tropical Cyclone Idai affects 1.5 million across Mozambique and Malawi, as UN ramps up response

Germany rules the banking industry of Eurozone

Google strongly rejects EU antitrust charges and now gets ready for the worst to come

Labels for tyres: deal for greener and safer road transport

Why people with disabilities are your company’s untapped resource

The Fourth Industrial Revolution must not leave farming behind

Agreement on linking the emissions trading systems of the EU and Switzerland

Political solution ‘long overdue’ to protect the children of eastern Ukraine

Europe plans to send satellites into space to monitor CO2 emissions

UN General Assembly President upholds value of multilateralism in speech closing annual debate

‘Air bridge’ vaccination operation begins for Ebola-hit communities in DR Congo

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s